News | Proton Therapy | May 25, 2022

Proof of feasibility of downsizing to the world's smallest size, and moved to final confirmation for application for PMDA approval

The ultra-compact proton therapy system used in the POC (Photo: Business Wire)

The ultra-compact proton therapy system used in the POC (Photo: Business Wire)


May 25, 2022 — B dot Medical Inc. and Research Center for Nuclear Physics, Osaka University (RCNP) have conducted a Proof of Concept (POC) of the ultra-compact proton therapy system under development and confirmed that the proton beam generated by an accelerator was bent inside the superconducting bending magnet in the system and irradiated to the isocenter (*1). That proves the feasibility of the development concept of downsizing the device and is a major step forward in improving access to cancer treatment with fewer side effects.

This POC was conducted as part of the International Joint Usage/Research Center program promoted by the Research Center for Nuclear Physics (RCNP) at Osaka University and is also the first experimental research using the upgraded AVF cyclotron beam at the Accelerator Facility of the RCNP. In the POC, the proton beam generated by the accelerator was passed through a superconducting bending magnet (*2) developed in-house, and it was confirmed that the proton beam was irradiated to the isocenter by being bent to an arbitrary angle in the bending magnet.

For more information: https://bdotmed.co.jp/en/

References:

*1

The Isocenter is the intersection of each mechanical rotation axis.

 

In radiation therapy, it refers to the area where the radiation is most concentrated.

 

(by “Guidelines of Physical and Technological Quality Assurance for Particle Beam Therapy”)

 

 

*2

Press release, June 25, 2021

 

“B dot Medical Successfully Develops Compact Bending Magnet for Proton Beam Using Superconducting Technology”

 

https://bdotmed.co.jp/en/news/20210625/


Related Content

News | Prostate Cancer

July 30, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 25, 2024 — NorthStar Medical Radioisotopes, LLC and BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc ...

Time July 25, 2024
arrow
News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | ASTRO

June 21, 2024 — The American Society for Radiation Oncology (ASTRO) announced today that following a nationwide search ...

Time June 21, 2024
arrow
News | Proton Therapy

June 14, 2024 — Atlantic Health System, an integrated health care system setting standards for quality health care in ...

Time June 14, 2024
arrow
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 14, 2024
arrow
News | SNMMI

June 13, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) hosted more than 8,000 physicians ...

Time June 13, 2024
arrow
News | PET-CT

June 13, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 13, 2024
arrow
News | Radiology Business

June 12, 2024 — Cathy Sue Cutler, PhD, FSNMMI, chair of the Isotope Research and Production Department at Brookhaven ...

Time June 12, 2024
arrow
News | SPECT-CT

June 11, 2024 — A newly developed radiotracer can generate high quality and readily interpretable images of cardiac ...

Time June 11, 2024
arrow
Subscribe Now